450 related articles for article (PubMed ID: 32531867)
1. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Silverstein J; Roll G; Dodge JL; Grab JD; Yao FY; Mehta N
Liver Transpl; 2020 Sep; 26(9):1100-1111. PubMed ID: 32531867
[TBL] [Abstract][Full Text] [Related]
2. The Use of Donation After Cardiac Death Allografts Does Not Increase Recurrence of Hepatocellular Carcinoma.
Croome KP; Lee DD; Burns JM; Musto K; Paz D; Nguyen JH; Perry DK; Harnois DM; Taner CB
Am J Transplant; 2015 Oct; 15(10):2704-11. PubMed ID: 25968609
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes of Early Experience in Donation After Circulatory Death Liver Transplantation: Outcomes at 10 Years.
Haque OJ; Roth EM; Fleishman A; Eckhoff DE; Khwaja K
Ann Transplant; 2021 Apr; 26():e930243. PubMed ID: 33875633
[TBL] [Abstract][Full Text] [Related]
4. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.
Kollmann D; Sapisochin G; Goldaracena N; Hansen BE; Rajakumar R; Selzner N; Bhat M; McCluskey S; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Liver Transplantation Using Machine Perfusion in Donation after Cardiac Death vs Brain Death in the US.
Okumura K; Dhand A; Misawa R; Sogawa H; Veillette G; Nishida S
J Am Coll Surg; 2023 Jan; 236(1):73-80. PubMed ID: 36519910
[TBL] [Abstract][Full Text] [Related]
6. Early Outcomes of Liver Transplantation Using Donors After Circulatory Death in Patients With Hepatocellular Carcinoma: A Comparative Study.
Martinez-Insfran LA; Ramirez P; Cascales P; Alconchel F; Ferreras D; Febrero B; Martinez M; González MR; Sanchez-Bueno F; Robles R; Parrilla P
Transplant Proc; 2019 Mar; 51(2):359-364. PubMed ID: 30879541
[TBL] [Abstract][Full Text] [Related]
7. Donation after circulatory death liver transplantation: An in-depth analysis and propensity score-matched comparison.
Hobeika MJ; Saharia A; Mobley CM; Menser T; Nguyen DT; Graviss EA; McMillan RR; Podder H; Nolte Fong JV; Jones SL; Yi SG; Elshawwaf M; Gaber AO; Ghobrial RM
Clin Transplant; 2021 Jun; 35(6):e14304. PubMed ID: 33792971
[TBL] [Abstract][Full Text] [Related]
8. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort.
Croome KP; Lee DD; Perry DK; Burns JM; Nguyen JH; Keaveny AP; Taner CB
Liver Transpl; 2017 Mar; 23(3):342-351. PubMed ID: 28027600
[TBL] [Abstract][Full Text] [Related]
9. Liver transplant after donation from controlled circulatory death versus brain death: A UNOS database analysis and publication bias adjusted meta-analysis.
Ziogas IA; Kakos CD; Esagian SM; Skarentzos K; Alexopoulos SP; Shingina A; Montenovo MI
Clin Transplant; 2022 Feb; 36(2):e14521. PubMed ID: 34689372
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
11. Renal Dysfunction After Liver Transplantation: Effect of Donor Type.
Kollmann D; Neong SF; Rosales R; Hansen BE; Sapisochin G; McCluskey S; Bhat M; Cattral MS; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M; Wong FSH; Selzner N
Liver Transpl; 2020 Jun; 26(6):799-810. PubMed ID: 32189415
[TBL] [Abstract][Full Text] [Related]
12. Lower Alpha-Fetoprotein Threshold of 500 ng/mL for Liver Transplantation May Improve Posttransplant Outcomes in Patients With Hepatocellular Carcinoma.
Goldman ML; Zhou K; Dodge JL; Yao F; Mehta N
Liver Transpl; 2022 May; 28(5):763-773. PubMed ID: 34927344
[TBL] [Abstract][Full Text] [Related]
13. Longterm results of liver transplantation from donation after circulatory death.
Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
[TBL] [Abstract][Full Text] [Related]
14. DCD liver transplant in patients with a MELD over 35.
Meier RPH; Nunez M; Syed SM; Feng S; Tavakol M; Freise CE; Roberts JP; Ascher NL; Hirose R; Roll GR
Front Immunol; 2023; 14():1246867. PubMed ID: 37731493
[TBL] [Abstract][Full Text] [Related]
15. Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernández-de la Varga M; Del Pozo-Del Valle P; Béjar-Serrano S; López-Andújar R; Berenguer M; Prieto M; Montalvá E; Aguilera V
Ann Hepatol; 2022; 27(5):100724. PubMed ID: 35643260
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study.
Meier RPH; Kelly Y; Braun H; Maluf D; Freise C; Ascher N; Roberts J; Roll G
Transpl Int; 2022; 35():10855. PubMed ID: 36568142
[TBL] [Abstract][Full Text] [Related]
17. Differential Impact of Extended Criteria Donors After Brain Death or Circulatory Death in Adult Liver Transplantation.
Pandya K; Sastry V; Panlilio MT; Yip TCF; Salimi S; West C; Virtue S; Wells M; Crawford M; Pulitano C; Strasser SI; McCaughan GW; Majumdar A; Liu K
Liver Transpl; 2020 Dec; 26(12):1603-1617. PubMed ID: 32750732
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation.
Nutu A; Justo I; Marcacuzco A; Caso Ó; Manrique A; Calvo J; García-Sesma Á; García-Conde M; Gallego MS; Jiménez-Romero C
Sci Rep; 2021 Jun; 11(1):13520. PubMed ID: 34188156
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
[TBL] [Abstract][Full Text] [Related]
20. Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.
Bohorquez H; Seal JB; Cohen AJ; Kressel A; Bugeaud E; Bruce DS; Carmody IC; Reichman TW; Battula N; Alsaggaf M; Therapondos G; Bzowej N; Tyson G; Joshi S; Nicolau-Raducu R; Girgrah N; Loss GE
Am J Transplant; 2017 Aug; 17(8):2155-2164. PubMed ID: 28276658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
